XML 71 R54.htm IDEA: XBRL DOCUMENT v3.25.1
Schedule of financial information of the joint venture and associate (Details)
 12 Months Ended
Dec. 31, 2024
USD ($)
Dec. 31, 2024
SGD ($)
Dec. 31, 2023
SGD ($)
Dec. 31, 2022
SGD ($)
Dec. 31, 2024
SGD ($)
Defined Benefit Plan Disclosure [Line Items]          
Current assets $ 1,217,401   $ 1,435,049   $ 1,656,030
Current liabilities 4,440,953   4,425,473   6,041,029
Net sales or gross revenue 37,745 $ 51,345 64,168 $ 36,621  
Gross profit (2,223) (3,024) 36,605 19,978  
Net loss (1,147,199) (1,560,535) (1,119,555) (1,094,516)  
Net loss attributable to the Company (38,176) (51,931) (33,788) (7,345)  
Biotherapeutic Solutions Sdn Bhd [Member]          
Defined Benefit Plan Disclosure [Line Items]          
Current assets     22,743
Current liabilities     6,670
Net sales or gross revenue       3,370  
Gross profit       2,532  
Net loss   (15,780) (14,690)  
Net loss attributable to the Company   (7,890) (7,345)  
Cuprina Mena Co Ltd [Member]          
Defined Benefit Plan Disclosure [Line Items]          
Current assets     17,580 9,447
Current liabilities     35,274 164,840
Net sales or gross revenue        
Gross profit        
Net loss   (105,981) (52,854)  
Net loss attributable to the Company   (51,931) (25,898)  
Joint Venture And Associate [Member]          
Defined Benefit Plan Disclosure [Line Items]          
Current assets 6,945   17,580 22,743 9,447
Current liabilities 121,179   35,274 6,670 $ 164,840
Net sales or gross revenue       3,370  
Gross profit       2,532  
Net loss (77,910) (105,981) (68,364) (14,690)  
Net loss attributable to the Company $ (38,176) $ (51,931) $ (33,788) $ (7,345)